Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TMCITREACE MEDICAL CONCEPTS, INC.

Nasdaq · CIK 0001630627
Filer categoryAccelerated filer
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts289

Identity from submissions API

NameTREACE MEDICAL CONCEPTS, INC.
CIK0001630627
TickersTMCI
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC3841 Surgical & Medical Instruments & Apparatus
EIN471052611
LEI—
Fiscal year end1231
State of incorporationFL FL
Phone(904) 373-5940
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
100 PALMETTO PARK PLACE
PONTE VEDRA
FL
32081
FL
Mailing address
100 PALMETTO PARK PLACE
PONTE VEDRA
FL
32081
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

447 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005301 005-93221 261559237 34 10061
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005257 005-93221 261558220 34 10253
2026-11-06 10-Q 10-Q 0001193125-26-450722 001-40355 261529306 34 8211951 1 1
2026-11-06 8-K 8-K 2.02,9.01 0001193125-26-450715 001-40355 261529300 34 751045 1 1
2026-10-28 4 4 0001193125-26-436510 4965
2026-10-02 4 4 0001193125-26-412727 4825
2026-08-24 4 4 0001193125-26-363737 11963
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003617 005-93221 261277310 34 10500
2026-08-12 4 4 0001193125-26-347275 4966
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-347227 005-93221 261268935 34 7323
2026-08-12 4 4 0001193125-26-347223 4719
2026-08-12 4 4 0001193125-26-347222 4767
2026-08-07 10-Q 10-Q 0001630627-26-000018 001-40355 261251391 34 8149847 1 1
2026-08-07 8-K 8-K 2.02,9.01 0001630627-26-000017 001-40355 261251390 34 726478 1 1
2026-07-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003113 005-93221 261221114 34 10797
2026-06-12 4/A 4/A 0001193125-26-268606 11386
2026-06-11 4 4 0001193125-26-267800 10551
2026-06-01 4 4 0001193125-26-251587 8604
2026-05-28 4 4 0001193125-26-245341 12497
2026-05-20 8-K 8-K 5.07,9.01 0001630627-26-000014 001-40355 261005225 34 194486 1 1
2026-05-19 4 4 0001193125-26-231466 6843
2026-05-19 4 4 0001193125-26-231464 5318
2026-05-19 4 4 0001193125-26-231462 5322
2026-05-19 4 4 0001193125-26-231463 5076
2026-05-19 4 4 0001193125-26-231461 5362
2026-05-19 4 4 0001193125-26-231459 5374
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002152 005-93221 26984155 34 10496
2026-05-14 4 4 0001193125-26-224391 12496
2026-05-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000070858-26-000302 005-93221 26979028 34 171307
2026-05-08 S-8 S-8 0001630627-26-000011 333-295702 26958237 33 638406 1 1
2026-05-08 10-Q 10-Q 0001193125-26-213322 001-40355 26956029 34 7093302 1 1
2026-05-08 8-K 8-K 2.02,9.01 0001193125-26-213267 001-40355 26956013 34 624002 1 1
2026-04-20 4 4 0001193125-26-164654 4718
2026-04-09 8-K 8-K 2.02,5.02,7.01 0001630627-26-000010 001-40355 26849783 34 181392 1 1
2026-04-06 ARS ARS 0001630627-26-000007 001-40355 26839697 34 5618606
2026-04-06 DEFA14A DEFA14A 0001630627-26-000006 001-40355 26839694 34 1168224
2026-04-06 DEF 14A DEF 14A 0001630627-26-000005 001-40355 26839693 34 39954939 1 1
2026-04-03 4 4 0001193125-26-142647 5259
2026-03-11 4 4 0001193125-26-102764 6111
2026-03-11 4 4 0001193125-26-102763 6097
2026-03-11 4 4 0001193125-26-102762 9400
2026-03-11 4 4 0001193125-26-102761 6063
2026-02-27 10-K 10-K 0001193125-26-079167 001-40355 26692566 34 55447844 1 1
2026-02-27 8-K 8-K 2.02,9.01 0001193125-26-079163 001-40355 26692555 34 768144 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001222 005-93221 26645044 34 10534
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001019056-26-000033 005-93221 26627961 34 12055
2026-02-11 4 4 0001193125-26-047313 6908
2026-02-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001644956-26-000008 005-93221 26611131 34 6677
2026-01-23 4 4 0001193125-26-021453 5147
2026-01-23 4 4 0001193125-26-021452 6627
2026-01-23 4 4 0001193125-26-021451 6580
2026-01-23 4 4 0001193125-26-021450 8902
2026-01-23 4 4 0001193125-26-021449 9926
2026-01-13 4 4 0001193125-26-012082 4580
2026-01-13 4 4 0001193125-26-012081 4628
2026-01-13 4 4 0001193125-26-012080 7927
2026-01-13 8-K 8-K 2.02,7.01,9.01 0001193125-26-011177 001-40355 26528548 34 10539414 1 1
2025-12-18 8-K 8-K 1.01,1.02,2.03,3.03,7.01,8.01,9.01 0001193125-25-323802 001-40355 251581407 34 248416 1 1
2025-12-03 4 4 0001193125-25-307269 6017
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005159 005-93221 251488673 34 10664
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001644956-25-000047 005-93221 251474604 34 6531
2025-11-06 10-Q 10-Q 0001193125-25-269556 001-40355 251458471 34 7908821 1 1
2025-11-06 8-K 8-K 2.02,5.02,9.01 0001193125-25-269481 001-40355 251458250 34 732628 1 1
2025-10-28 4 4 0001193125-25-253801 4614
2025-10-28 4 4 0001193125-25-253800 4628
2025-10-02 4 4 0001193125-25-228960 6113
2025-08-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003633 005-93221 251223544 34 10661
2025-08-12 4 4 0000950170-25-107557 4630
2025-08-12 4 4 0000950170-25-107556 4582
2025-08-12 4 4 0000950170-25-107555 4615
2025-08-12 4 4 0000950170-25-107554 4598
2025-08-07 10-Q 10-Q 0000950170-25-105059 001-40355 251194326 34 7804510 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-105039 001-40355 251194175 34 730902 1 1
2025-07-22 4 4 0000950170-25-097601 7120
2025-05-21 4 4 0000950170-25-075894 4937
2025-05-21 4 4 0000950170-25-075893 5184
2025-05-21 4 4 0000950170-25-075892 5224
2025-05-21 4 4 0000950170-25-075891 5180
2025-05-21 4 4 0000950170-25-075890 5236
2025-05-21 4 4 0000950170-25-075889 5192
2025-05-21 4 4 0000950170-25-075888 6705
2025-05-21 8-K 8-K 5.07,9.01 0000950170-25-075805 001-40355 25973534 34 191920 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001344676-25-000030 005-93221 25954044 34 20328
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002231 005-93221 25951874 34 10669
2025-05-12 4 4 0000950170-25-069492 6422
2025-05-09 S-8 S-8 0000950170-25-067555 333-287119 25928527 33 376934
2025-05-08 10-Q 10-Q 0000950170-25-066953 001-40355 25926151 34 7395458 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066915 001-40355 25925934 34 613630 1 1
2025-04-07 DEF 14A DEF 14A 0000950170-25-051369 001-40355 25816428 34 43148193 1 1
2025-04-07 ARS ARS 0000950170-25-051368 001-40355 25816426 34 6851900
2025-04-07 8-K 8-K 5.02,9.01 0000950170-25-051362 001-40355 25816409 34 212612 1 1
2025-04-07 DEFA14A DEFA14A 0000950170-25-051363 001-40355 25816408 34 1551606
2025-03-19 4 4 0000950170-25-042291 9060
2025-03-17 144 xsl144X01/primary_doc.xml 0001950047-25-001980 001-40355 25745221 33 4807
2025-03-11 4 4 0000950170-25-037575 6085
2025-03-11 4 4 0000950170-25-037574 9416
2025-03-11 4 4 0000950170-25-037572 6104
2025-03-11 4 4 0000950170-25-037569 6118
2025-03-11 4 4 0000950170-25-037566 6070
2025-03-04 4 4 0000950170-25-032626 8472
2025-02-27 10-K 10-K 0000950170-25-029029 001-40355 25678692 34 62845943 1 1
2025-02-27 8-K 8-K 2.02,9.01 0000950170-25-029009 001-40355 25678611 34 704922 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001270 005-93221 25631049 34 10682
2025-02-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000201 005-93221 25583147 34 8126
2025-01-24 4 4 0000950170-25-008974 5118
2025-01-24 4 4 0000950170-25-008973 5136
2025-01-24 4 4 0000950170-25-008972 5149
2025-01-24 4 4 0000950170-25-008971 8446
2025-01-24 4 4 0000950170-25-008970 5212
2025-01-14 4 4 0000950170-25-005582 5276
2025-01-14 4 4 0000950170-25-005580 4835
2025-01-14 4 4 0000950170-25-005579 4635
2025-01-14 4 4 0000950170-25-005578 4603
2025-01-14 4 4 0000950170-25-005577 7932
2025-01-13 8-K 8-K 2.02,7.01,9.01 0000950170-25-004578 001-40355 25524901 34 11808834 1 1
2024-12-05 4 4 0000950170-24-133720 7039
2024-12-05 3 3 0000950170-24-133716 19189
2024-11-14 SC 13G armistice-tmci093024.htm 0001172661-24-005109 005-93221 241461129 34 90781
2024-11-13 4 4 0000950170-24-126551 6434
2024-11-12 SC 13G/A UnitedStates_13G__TreaceMedi.txt 0000932471-24-001303 005-93221 241450353 34 6583
2024-11-08 SC 13G MS INITIAL 0000895421-24-000631 005-93221 241440243 34 12699
2024-11-07 SC 13G/A SC 13G/A 0000950170-24-123492 005-93221 241436871 34 68491
2024-11-05 10-Q 10-Q 0000950170-24-121460 001-40355 241427510 34 7136972 1 1
2024-11-05 8-K 8-K 2.02,9.01 0000950170-24-121456 001-40355 241427451 34 592987 1 1
2024-11-04 SC 13G/A UnitedStates_13G__TreaceMedi.txt 0000932471-24-000731 005-93221 241422497 34 5626
2024-10-15 8-K 8-K 7.01,9.01 0000950170-24-114699 001-40355 241372111 34 207694 1 1
2024-10-02 4 4 0000950170-24-111853 5101
2024-09-17 4 4 0000950170-24-107401 8473
2024-09-16 4 4 0000950170-24-106856 6921
2024-08-19 4 4 0000950170-24-098286 5609
2024-08-15 4 4 0000950170-24-097694 8473
2024-08-09 4 4 0000950170-24-095010 5069
2024-08-09 4 4 0000950170-24-095009 5087
2024-08-09 4 4 0000950170-24-095008 5742
2024-08-09 4 4 0000950170-24-095007 5101
2024-08-06 10-Q 10-Q 0000950170-24-091787 001-40355 241179234 34 6870992 1 1
2024-08-06 8-K 8-K 2.02,9.01 0000950170-24-091777 001-40355 241179124 34 581953 1 1
2024-06-11 4 4 0000950170-24-072078 8474
2024-06-03 4 4 0000950170-24-068023 5609
2024-05-30 4 4 0000950170-24-066745 5609
2024-05-29 4 4 0000950170-24-065984 5608
2024-05-28 4 4 0000950170-24-065263 5038
2024-05-23 4 4 0000950170-24-063988 5038
2024-05-22 4 4 0000950170-24-063614 7659
2024-05-22 4 4 0000950170-24-063616 7647
2024-05-22 4 4 0000950170-24-063612 7404
2024-05-22 4 4 0000950170-24-063617 9186
2024-05-22 4 4 0000950170-24-063613 7651
2024-05-22 4 4 0000950170-24-063615 7703
2024-05-22 4 4 0000950170-24-063611 7691
2024-05-22 8-K 8-K 5.07,9.01 0000950170-24-063565 001-40355 24974182 34 199812 1 1
2024-05-20 4 4 0000950170-24-062435 8476
2024-05-14 4 4 0000950170-24-059856 5027
2024-05-14 4 4 0000950170-24-059854 8483
2024-05-13 4 4 0000950170-24-058990 4491
2024-05-13 4 4 0000950170-24-058989 6984
2024-05-13 4 4 0000950170-24-058986 7517
2024-05-13 4 4 0000950170-24-058974 6508
2024-05-13 4 4 0000950170-24-058878 10431
2024-05-09 S-8 S-8 0000950170-24-057076 333-279266 24931261 33 237109
2024-05-07 10-Q 10-Q 0000950170-24-054480 001-40355 24921909 34 6636511 1 1
2024-05-07 8-K 8-K 2.02,7.01,9.01 0000950170-24-054475 001-40355 24921861 34 8689697 1 1
2024-04-02 DEFA14A DEFA14A 0000950170-24-040229 001-40355 24814729 34 1230872
2024-04-02 DEF 14A DEF 14A 0000950170-24-040228 001-40355 24814730 34 2587051
2024-04-02 ARS ARS 0000950170-24-040137 001-40355 24814132 34 3658811
2024-03-29 4 4 0000950170-24-038822 11106
2024-03-12 4 4 0000950170-24-030473 6088
2024-03-12 4 4 0000950170-24-030474 6766
2024-03-12 4 4 0000950170-24-030472 9425
2024-03-12 4 4 0000950170-24-030429 6103
2024-03-12 4 4 0000950170-24-030426 6124
2024-02-27 10-K 10-K 0000950170-24-021228 001-40355 24687333 34 25692966 1 1
2024-02-27 8-K 8-K 2.02,7.01,9.01 0000950170-24-021152 001-40355 24686871 34 11816657 1 1
2024-02-14 SC 13G/A SEC SCHEDULE 13G 0001532155-24-000094 005-93221 24636645 34 18226
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022127 005-93221 24629718 34 13088
2024-02-09 SC 13G/A SC 13G/A 0000950170-24-013360 005-93221 24615905 34 68162
2024-01-29 SC 13G us89455t1097_012924.txt 0001086364-24-005603 005-93221 24574947 34 13615
2024-01-12 4 FORM 4 SUBMISSION 0001209191-24-001593 7883
2024-01-12 4 FORM 4 SUBMISSION 0001209191-24-001592 7951
2024-01-12 4 FORM 4 SUBMISSION 0001209191-24-001591 8550
2024-01-12 4 FORM 4 SUBMISSION 0001209191-24-001590 8689
2024-01-12 4 FORM 4 SUBMISSION 0001209191-24-001589 7887
2024-01-10 8-K 8-K 7.01,9.01 0000950170-24-003448 001-40355 24524422 34 16417780 1 1
2024-01-08 8-K 8-K 2.02,9.01 0000950170-24-002719 001-40355 24518461 34 212651 1 1
2023-11-09 10-Q 10-Q 0000950170-23-062068 001-40355 231392590 34 8915990 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-062026 001-40355 231392387 34 846940 1 1
2023-11-03 4 FORM 4 SUBMISSION 0001209191-23-054434 4789
2023-11-03 4 FORM 4 SUBMISSION 0001209191-23-054433 4727
2023-10-05 4 FORM 4 SUBMISSION 0001209191-23-052266 4789
2023-08-09 10-Q 10-Q 0000950170-23-040159 001-40355 231153450 34 8954362 1 1
2023-08-08 8-K 8-K 2.02,9.01 0000950170-23-039795 001-40355 231151293 34 939983 1 1
2023-06-14 144 xsl144X01/primary_doc.xml 0001972362-23-000393 001-40355 231015417 33 4570
2023-06-13 8-K 8-K 2.01,9.01 0000950170-23-027758 001-40355 231012092 34 231852 1 1
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035400 5971
2023-06-05 144 xsl144X01/primary_doc.xml 0001958244-23-000842 001-40355 23994068 33 11888
2023-06-02 144 xsl144X01/primary_doc.xml 0001958244-23-000837 001-40355 23990518 33 11104
2023-06-01 8-K 8-K 7.01,8.01,9.01 0000950170-23-025707 001-40355 23984915 34 4110442 1 1
2023-05-26 8-K 8-K 5.07 0000950170-23-024559 001-40355 23970346 34 220464 1 1
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032353 7961
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032351 8484
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032352 7906
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032355 7949
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032350 7902
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032354 9482
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032349 7661
2023-05-18 4 FORM 4 SUBMISSION 0001209191-23-030857 9523
2023-05-09 10-Q 10-Q 0000950170-23-019154 001-40355 23900057 34 8008073 1 1
2023-05-08 8-K 8-K 2.02,9.01 0000950170-23-018823 001-40355 23897908 34 695523 1 1
2023-05-02 4 FORM 4 SUBMISSION 0001209191-23-026796 10076
2023-05-01 144 xsl144X01/primary_doc.xml 0001971857-23-000031 001-40355 23871671 33 7142
2023-04-28 4 FORM 4 SUBMISSION 0001209191-23-026167 7187
2023-04-26 144 xsl144X01/primary_doc.xml 0001958244-23-000473 001-40355 23850822 33 13486
2023-04-13 4 FORM 4 SUBMISSION 0001209191-23-024260 9283
2023-04-11 144 xsl144X01/primary_doc.xml 0001958244-23-000446 001-40355 23813933 33 11840
2023-04-10 4 FORM 4 SUBMISSION 0001209191-23-023948 5295
2023-04-05 4 FORM 4 SUBMISSION 0001209191-23-023543 6900
2023-04-04 ARS ARS 0000950170-23-011795 001-40355 23798836 34 4534793
2023-04-04 DEFA14A DEFA14A 0000950170-23-011693 001-40355 23795103 34 3300323
2023-04-04 DEF 14A DEF 14A 0000950170-23-011691 001-40355 23795095 34 3104079
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021956 7432
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021955 5891
2023-03-30 4 FORM 4 SUBMISSION 0001209191-23-021741 7189
2023-03-17 4 FORM 4 SUBMISSION 0001209191-23-019944 9511
2023-03-17 4 FORM 4 SUBMISSION 0001209191-23-019943 6987
2023-03-15 4 FORM 4 SUBMISSION 0001209191-23-019078 9249
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018046 13142
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018044 9766
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018045 10551
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018043 9768
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018042 9737
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018041 9843
2023-03-10 4 FORM 4 SUBMISSION 0001209191-23-018040 8478
2023-03-10 8-K 8-K 8.01 0000950170-23-007283 001-40355 23723744 34 166216 1 1
2023-03-08 S-8 S-8 0001193125-23-064488 333-270352 23716182 33 89041
2023-03-08 10-K 10-K 0000950170-23-006603 001-40355 23714977 34 21425162 1 1
2023-03-07 8-K 8-K 2.02,9.01 0000950170-23-006457 001-40355 23712656 34 943413 1 1
2023-03-03 4 FORM 4 SUBMISSION 0001209191-23-016093 5265
2023-03-02 4 FORM 4 SUBMISSION 0001209191-23-015075 7949
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012441 7155
2023-02-23 8-K 8-K 5.02 0000950170-23-004148 001-40355 23660270 34 167882 1 1
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010955 9252
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010852 7942
2023-02-14 5 FORM 5 SUBMISSION 0001209191-23-009582 6368
2023-02-14 SC 13G SEC SCHEDULE 13G 0001532155-23-000056 005-93221 23620858 34 18137
2023-02-13 SC 13G/A SC 13G/A 0001193125-23-035743 005-93221 23618385 34 41084
2023-02-13 SC 13G/A SC 13G/A 0001193125-23-035682 005-93221 23618184 34 41579
2023-02-10 8-K 8-K 1.01,8.01,9.01 0001193125-23-032511 001-40355 23611677 34 457035 1 1
2023-02-09 4 FORM 4 SUBMISSION 0001209191-23-008200 7155
2023-02-09 SC 13G SCHEDULE 13G 0001104659-23-017129 005-93221 23604428 34 12954
2023-02-09 424B5 424B5 0001193125-23-028748 333-269622 23600642 33 1032244
2023-02-07 424B5 424B5 0001193125-23-027039 333-269622 23595929 33 1006927
2023-02-07 S-3ASR S-3ASR 0001193125-23-026932 333-269622 23595233 33 640515
2023-02-03 4 FORM 4 SUBMISSION 0001209191-23-007201 4734
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006465 5858
2023-01-30 4 FORM 4 SUBMISSION 0001209191-23-005547 10047
2023-01-30 4 FORM 4 SUBMISSION 0001209191-23-005543 9538
2023-01-26 4 FORM 4 SUBMISSION 0001209191-23-005131 9251
2023-01-20 4 FORM 4 SUBMISSION 0001209191-23-004342 6985
2023-01-19 4 FORM 4 SUBMISSION 0001209191-23-004143 5265
2023-01-13 4 FORM 4 SUBMISSION 0001209191-23-003385 9252
2023-01-13 4 FORM 4 SUBMISSION 0001209191-23-003384 7400
2023-01-13 4 FORM 4 SUBMISSION 0001209191-23-003383 9582
2023-01-09 4 FORM 4 SUBMISSION 0001209191-23-002675 7399
2023-01-09 8-K 8-K 2.02,9.01 0000950170-23-000442 001-40355 23516691 34 231086 1 1
2022-12-30 4 FORM 4 SUBMISSION 0001209191-22-063055 5266
2022-12-21 4 FORM 4 SUBMISSION 0001209191-22-062379 7156
2022-12-16 4 FORM 4 SUBMISSION 0001209191-22-061757 6988
2022-12-14 4 FORM 4 SUBMISSION 0001209191-22-061323 5860
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060617 7148
2022-12-02 4 FORM 4 SUBMISSION 0001209191-22-059533 7254
2022-12-02 4 FORM 4 SUBMISSION 0001209191-22-059532 14625
2022-11-30 4 FORM 4 SUBMISSION 0001209191-22-059128 7150
2022-11-22 4 FORM 4 SUBMISSION 0001209191-22-058549 13879
2022-11-21 4 FORM 4 SUBMISSION 0001209191-22-058268 4685
2022-11-21 4 FORM 4 SUBMISSION 0001209191-22-058266 8631
2022-11-18 4 FORM 4 SUBMISSION 0001209191-22-058000 6985
2022-11-17 4 FORM 4 SUBMISSION 0001209191-22-057743 5298
2022-11-17 4 FORM 4 SUBMISSION 0001209191-22-057740 9409
2022-11-17 4 FORM 4 SUBMISSION 0001209191-22-057654 8632
2022-11-16 4 FORM 4 SUBMISSION 0001209191-22-057418 9202
2022-11-14 4 FORM 4 SUBMISSION 0001209191-22-056467 11337
2022-11-09 10-Q 10-Q 0000950170-22-023530 001-40355 221370791 34 7803550 1 1
2022-11-08 8-K 8-K 2.02,9.01 0000950170-22-023221 001-40355 221369009 34 914589 1 1
2022-11-02 4 FORM 4 SUBMISSION 0001209191-22-055176 5193
2022-11-01 4 FORM 4 SUBMISSION 0001209191-22-055133 5162
2022-10-26 4 FORM 4 SUBMISSION 0001209191-22-054666 7665
2022-10-21 4 FORM 4 SUBMISSION 0001209191-22-054342 10050
2022-10-20 4 FORM 4 SUBMISSION 0001209191-22-054211 9237
2022-10-07 4 FORM 4 SUBMISSION 0001209191-22-053169 7155
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052526 7565
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052525 7566
2022-10-04 3 FORM 3 SUBMISSION 0001209191-22-052448 7167
2022-10-04 4 FORM 4 SUBMISSION 0001209191-22-052447 7772
2022-10-04 3 FORM 3 SUBMISSION 0001209191-22-052446 7301
2022-09-29 4 FORM 4 SUBMISSION 0001209191-22-051555 7155
2022-09-28 8-K 8-K 5.02,9.01 0000950170-22-018920 001-40355 221272465 34 209163 1 1
2022-09-16 4 FORM 4 SUBMISSION 0001209191-22-050424 8047
2022-09-15 4 FORM 4 SUBMISSION 0001209191-22-050143 11337
2022-09-02 4 FORM 4 SUBMISSION 0001209191-22-048607 14696
2022-09-01 4 FORM 4 SUBMISSION 0001209191-22-048290 8638
2022-08-31 4 FORM 4 SUBMISSION 0001209191-22-048172 7161
2022-08-29 4 FORM 4 SUBMISSION 0001209191-22-047786 8638
2022-08-24 4 FORM 4 SUBMISSION 0001209191-22-047407 10735
2022-08-19 4 FORM 4 SUBMISSION 0001209191-22-046956 7959
2022-08-17 4 FORM 4 SUBMISSION 0001209191-22-046491 6988
2022-08-16 4 FORM 4 SUBMISSION 0001209191-22-046000 8826
2022-08-10 10-Q 10-Q 0000950170-22-016277 001-40355 221150600 34 10548494 1 1
2022-08-09 8-K 8-K 2.02,9.01 0000950170-22-016039 001-40355 221148281 34 812117 1 1
2022-08-05 4 FORM 4 SUBMISSION 0001209191-22-044621 11584
2022-08-03 4 FORM 4 SUBMISSION 0001209191-22-044026 9352
2022-07-20 4 FORM 4 0001567619-22-014272 9726
2022-07-15 4 FORM 4 0001567619-22-014078 9728
2022-07-06 4 FORM 4 0001567619-22-013730 8542
2022-06-21 4 FORM 4 0001567619-22-013208 7860
2022-06-03 4 FORM 4 0001567619-22-012339 8541
2022-05-27 4 FORM 4 0001567619-22-011883 7863
2022-05-23 8-K 8-K 5.07 0000950170-22-010494 001-40355 22951681 34 217767 1 1
2022-05-20 4 FORM 4 0001567619-22-011443 5223
2022-05-19 4 FORM 4 0001567619-22-011345 11575
2022-05-19 4 FORM 4 0001567619-22-011344 9545
2022-05-19 4 FORM 4 0001567619-22-011343 7264
2022-05-19 4 FORM 4 0001567619-22-011342 11516
2022-05-19 4 FORM 4 0001567619-22-011341 7299
2022-05-19 4 FORM 4 0001567619-22-011340 8769
2022-05-11 4 FORM 4 0001567619-22-010102 8543
2022-05-11 4 FORM 4 0001567619-22-010101 12675
2022-05-06 10-Q 10-Q 0000950170-22-008018 001-40355 22899029 34 6519887 1 1
2022-05-05 8-K 8-K 2.02,9.01 0000950170-22-007826 001-40355 22896342 34 617798 1 1
2022-05-04 8-K 8-K 1.01,1.02,2.03,9.01 0000950170-22-007143 001-40355 22889079 34 246005 1 1
2022-04-04 DEFA14A DEFA14A 0000950170-22-005335 001-40355 22802977 34 395591
2022-04-04 DEF 14A DEF 14A 0000950170-22-005330 001-40355 22802735 34 1665086
2022-03-22 SC 13G/A TREACE MEDICAL 13 G AMENDMENT 0001298088-22-000008 005-93221 22757699 34 9003
2022-03-14 4 FORM 4 0001567619-22-006929 7494
2022-03-14 3 FORM 3 0001567619-22-006926 14784
2022-03-14 4 FORM 4 0001567619-22-006925 6917
2022-03-10 4 FORM 4 0001567619-22-006734 7480
2022-03-10 4 FORM 4 0001567619-22-006733 7479
2022-03-10 4 FORM 4 0001567619-22-006732 9483
2022-03-10 4 FORM 4 0001567619-22-006731 4484
2022-03-10 4 FORM 4 0001567619-22-006730 13024
2022-03-10 4 FORM 4 0001567619-22-006729 8149
2022-03-10 4 FORM 4 0001567619-22-006728 5347
2022-03-10 4 FORM 4 0001567619-22-006727 9118
2022-03-10 4 FORM 4 0001567619-22-006726 7474
2022-03-04 S-8 S-8 0001193125-22-066349 333-263327 22715421 33 78399
2022-03-04 4 FORM 4 0001567619-22-006400 8817
2022-03-04 10-K 10-K 0000950170-22-002903 001-40355 22714089 34 18437545 1 1
2022-03-03 8-K 8-K 2.02,9.01 0000950170-22-002793 001-40355 22708658 34 795058 1 1
2022-02-25 8-K 8-K 5.02 0000950170-22-002108 001-40355 22680683 34 186602 1 1
2022-02-11 5 FORM 5 0001567619-22-003544 16532
2022-02-11 5 FORM 5 0001567619-22-003543 6523
2022-02-11 SC 13G SC 13G 0001193125-22-037142 005-93221 22621518 34 42786
2022-02-11 5 FORM 5 0001567619-22-003539 6796
2022-02-11 SC 13G SC 13G 0001193125-22-037071 005-93221 22621185 34 42265
2022-02-10 4 FORM 4 0001567619-22-003261 14360
2022-01-20 4 FORM 4 0001567619-22-001384 10731
2022-01-12 4 FORM 4 0001567619-22-001142 22110
2022-01-12 8-K 8-K 2.02,9.01 0001193125-22-007689 001-40355 22526714 34 166689 1 1
2022-01-07 SC 13G/A TREACE MEDICAL CONCEPTS 0001298088-22-000002 005-93221 22516956 34 8438
2022-01-05 4 FORM 4 0001567619-22-000672 19548
2021-12-30 4 FORM 4 0001567619-21-022717 10713
2021-12-30 4 FORM 4 0001567619-21-022714 6758
2021-12-27 4 FORM 4 0001567619-21-022542 12698
2021-12-27 4 FORM 4 0001567619-21-022541 11072
2021-12-22 4 FORM 4 0001567619-21-022460 14681
2021-12-22 4 FORM 4 0001567619-21-022459 21714
2021-12-17 4 FORM 4 0001567619-21-022289 8747
2021-11-24 4 FORM 4 0001567619-21-021185 15375
2021-11-24 4 FORM 4 0001567619-21-021184 18643
2021-11-17 4 FORM 4 0001567619-21-020693 17314
2021-11-12 4 FORM 4 0001567619-21-020114 11007
2021-11-04 10-Q 10-Q 0001564590-21-054505 001-40355 211380284 34 8257363 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001564590-21-054483 001-40355 211380056 34 657470 1 1
2021-10-22 4 FORM 4 0001567619-21-018627 26920
2021-10-22 4 FORM 4 0001567619-21-018626 8893
2021-10-08 4 FORM 4 0001567619-21-018153 7468
2021-10-04 4 FORM 4 0001567619-21-017869 5540
2021-10-04 4 FORM 4 0001567619-21-017868 5481
2021-10-04 3 FORM 3 0001567619-21-017867 11698
2021-10-04 3 FORM 3 0001567619-21-017866 11554
2021-10-04 8-K 8-K NEW DIRECTORS 5.02,9.01 0001564590-21-049869 001-40355 211300902 34 217904 1 1
2021-09-21 4 FORM 4 0001567619-21-017391 5504
2021-09-21 3 FORM 3 0001567619-21-017390 11548
2021-08-05 4 FORM 4 0001567619-21-014559 5485
2021-08-05 3 FORM 3 0001567619-21-014557 12909
2021-08-05 10-Q 10-Q 0001564590-21-041667 001-40355 211149050 34 8446776 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001564590-21-041660 001-40355 211149015 34 627800 1 1
2021-05-28 10-Q/A 10-Q/A 0001193125-21-177028 001-40355 21980642 34 46759
2021-05-25 10-Q 10-Q 0001193125-21-172315 001-40355 21960679 34 4249648 1
2021-05-25 8-K 8-K 2.02,9.01 0001193125-21-172298 001-40355 21960605 34 113203
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017495 10556
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017486 13980
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017480 9920
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017476 11513
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017474 6250
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017470 13649
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017465 10089
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017462 17927
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017461 16038
2021-04-29 4 FORM 4 SUBMISSION 0000899243-21-017458 9293

Latest XBRL company facts

One latest value per concept from companyfacts (289 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 65.56M 2026-10-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
dei EntityPublicFloat Entity Public Float USD 265.90M 2025-06-30 2025 FY 10-K 2026-02-27 0001193125-26-079167
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 212.70M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD -497,833 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.06M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 76.03 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD -246,428 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
ecd PeoTotalCompAmt PeoTotalCompAmt USD 5.41M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 13.14 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
ffd NetFeeAmt NetFeeAmt USD 957.81 2026-05-08 S-8 2026-05-08 0001630627-26-000011
ffd TtlFeeAmt TtlFeeAmt USD 957.81 2026-05-08 S-8 2026-05-08 0001630627-26-000011
ffd TtlOfferingAmt TtlOfferingAmt USD 6.94M 2026-05-08 S-8 2026-05-08 0001630627-26-000011
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-08 S-8 2026-05-08 0001630627-26-000011
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 14.28M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 30.22M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -15,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AccruedInsuranceCurrentAndNoncurrent Accrued Insurance USD 200,000 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213322
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 7.24M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.31M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 1.60M 2026-03-31 2026 Q1 10-Q 2026-05-08 0001193125-26-213322
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 26.90M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -108,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 358.90M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 6.93M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 2.30M 2021-04-27 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 595,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap AdvertisingExpense Advertising Expense USD 6.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 21.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 1.80M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 2.10M 2024-04-01 2024-06-30 2024 Q2 10-Q 2024-08-06 0000950170-24-091787
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 300,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029029
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 747,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 14.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap Assets Assets USD 179.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AssetsCurrent Assets, Current USD 118.69M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 32.15M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 109,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 32.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 0 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
us-gaap CapitalizedComputerSoftwareAdditions Capitalized Computer Software, Additions USD 200,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap Cash Cash USD 5.36M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029029
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 7.76M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -7.35M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-06 0000950170-22-008018
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 7.76M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -2.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 85.84M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023530
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 0 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-054480
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 4.022 2019-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 713,330 2019-02-14 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062068
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 17.31M 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029029
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 65.87M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 62.28M 2024-09-30 2024 Q3 10-Q 2024-11-05 0000950170-24-121460
us-gaap CommonStockValue Common Stock, Value, Issued USD 66,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -46.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ContractWithCustomerRefundLiability Contract with Customer, Refund Liability USD 0 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ContractWithCustomerRightToRecoverProduct Contract with Customer, Right to Recover Product USD 0 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 6.69M 2021-04-27 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 29.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 60.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 3.74M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.67M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054505
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 3.33M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 908,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 60.34M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.31M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3.67M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 38.09M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.17M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 2.29M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses USD 726,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 6.92M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 56.67M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 17,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxLiabilitiesOtherFiniteLivedAssets Deferred Tax Liabilities, Other Finite-Lived Assets USD 1.89M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.76M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 2.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap Depreciation Depreciation USD 3.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 10.62M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 4.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap DerivativeLiabilities Derivative Liability USD 200,000 2022-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 2.50M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054505
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.71 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.16 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-06 0000950170-22-008018
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.71 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.13 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.09 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 10.54M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 4.10M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0000950170-24-054480
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023530
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 3.09M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 2.74M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 47.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap Goodwill Goodwill USD 12.81M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap GrossProfit Gross Profit USD 111.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ImpairmentOfLeasehold Impairment of Leasehold USD 100,000 2022-10-01 2022-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029029
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029029
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 8.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 315,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 5.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -456,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 697,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 7.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -11.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 3.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 6.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 272,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD -391,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -119,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 864,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 6.41M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap InterestExpense Interest Expense USD 4.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 2.92M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054505
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 3.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap InterestPayableCurrent Interest Payable, Current USD 574,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap InventoryNet Inventory, Net USD 42.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap InventoryWriteDown Inventory Write-down USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062068
us-gaap InvestmentIncomeNet Investment Income, Net USD 1.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 2.00M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 19.95M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 5.33M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.86M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.29M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.22M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.16M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.10M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 627,000 2021-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 5.42M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap Liabilities Liabilities USD 117.65M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 179.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap LiabilitiesCurrent Liabilities, Current USD 46.08M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029029
us-gaap LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage pure 0.005 2025-12-17 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LongTermDebt Long-term Debt USD 56.26M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 1.79M 2020-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 20.67M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023530
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 60.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 56.26M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap LongTermDebtPercentageBearingFixedInterestRate Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure 0.13 2020-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 0 2021-03-31 2021 Q1 10-Q 2021-05-25 0001193125-21-172315
us-gaap LossContingencyAccrualProductLiabilityNet Loss Contingency Accrual, Product Liability, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 32.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -180,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -227,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -2.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -713,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -46.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -49.53M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OperatingExpenses Operating Expenses USD 155.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -43.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 14.53M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 12.62M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.32M 2021-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 627,000 2021-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 321,000 2021-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 472,000 2021-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 458,000 2021-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 444,000 2021-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 172,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054505
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 600,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.094 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.94M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 856,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054505
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -56,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OtherLiabilities Other Liabilities USD 523,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.69M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -2.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 640,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap OtherReceivableAllowanceForCreditLossNoncurrent OtherReceivableAllowanceForCreditLossNoncurrent USD 17,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PaymentsForRent Payments for Rent USD 600,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 8.30M 2021-04-27 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 8,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-25 0001193125-21-172315
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 7.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 641,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 26.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 2.10M 2025-01-15 2024 FY 10-K 2025-02-27 0000950170-25-029029
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 140.07M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062068
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 7.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054505
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 6.37M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 1.80M 2020-04-22 2021 Q1 10-Q 2021-05-25 0001193125-21-172315
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 600,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 31.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 107,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ProductLiabilityContingencyAccrualPresentValue Product Liability Contingency, Accrual, Present Value USD 0 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -46.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 59.93M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 33.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap RentalIncomeNonoperating Rental Income, Nonoperating USD 300,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap RepaymentsOfDebt Repayments of Debt USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062068
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021228
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 13.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap RestructuringCharges Restructuring Charges USD 1.53M 2025-01-01 2025-12-31 DEF 14A 2026-04-06 0001630627-26-000005
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -295.39M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap Revenues Revenues USD 140.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-029029
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 17 2021-04-27 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 94.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 21.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 14.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.492 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-04 0000950170-22-002903
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.379 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.378 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.048 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062068
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.04 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.611 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062068
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.29M 2021-03-31 2021 Q1 10-Q 2021-05-25 0001193125-21-172315
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 6.11M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 10.85 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 5,183 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-25 0001193125-21-172315
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 877,910 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062068
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.96 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.21M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 7.16M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 11.97 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 2.21M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 2.21M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 7.10M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 11.91 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 500,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-25 0001193125-21-172315
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.53 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 13.86 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap SharePrice Share Price USD/shares 31.27 2021-04-28 2021 Q3 10-Q 2021-11-04 0001564590-21-054505
us-gaap ShortTermBorrowings Short-term Debt USD 3.78M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 61.65M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.338 2021-04-16 2022 FY 10-K 2023-03-08 0000950170-23-006603
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 356,446 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 107.53M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 8,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001630627-26-000018
us-gaap SubleaseIncome Sublease Income USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 348,299 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap TreasuryStockValue Treasury Stock, Value USD 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 12.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079167
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 65.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 54.83M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-06 0000950170-22-008018
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 65.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-450722

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →